This is a preview of subscription content, log in via an institution to check access.
References
Pink J, et al. Cost-effectiveness of pharmacogenetic guided warfarin therapy versus alternative anticoagulation in atrial fibrillation. 9th World Congress of the International Health Economics Association: Celebrating Health Economics : abstr. 4, 7 Jul 2013.
Hedegaard M, et al. Cost-Effectiveness of Budesonide/Formoterol Vs. Fluticasone/Salmeterol from a Swedish Healthcare Perspective Based on Real-World Effectiveness and Safety in Patients With COPD. 9th World Congress of the International Health Economics Association: Celebrating Health Economics : abstr. 1, 7 Jul 2013.
Gordon L, et al. A cost-effectiveness analysis of a telephone-linked care intervention for individuals with type 2 diabetes. 9th World Congress of the International Health Economics Association: Celebrating Health Economics : abstr. 2, 7 Jul 2013.
English K, et al. Evaluating the cost effectiveness of targeted vaccination strategies to reduce incidence of HPV-related cancer and other clinical outcomes in men who have sex with men (MSM) in British Columbia, Canada. 9th World Congress of the International Health Economics Association: Celebrating Health Economics : abstr. 2, 7 Jul 2013.
Hjortsberg C, et al. Health technology assessment (HTA) in the Nordics: same, same but different? -a practical example of a pharmaceutical reimbursement application. 9th World Congress of the International Health Economics Association: Celebrating Health Economics : abstr. 2, 7 Jul 2013.
Rights and permissions
About this article
Cite this article
News from iHEA. PharmacoEcon Outcomes News 683, 6–7 (2013). https://doi.org/10.1007/s40274-013-0572-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0572-6